{"title":"Decreased circulating CD39+ regulatory T cell frequencies following non-traumatic brain death.","authors":"Sedighe Poursaleh Amiri, Fattah Sotoudeh Nejad, Maryam Karamigolbaghi, Ehsan Jafari, Behrouz Robat-Jazi, Ahmadreza Sadeghi, Seyed Ghasem Poursaleh Amiri, Haideh Namdari, Ali Akbar Saboor-Yaraghi","doi":"10.1016/j.trim.2025.102219","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Regulatory T cells (Tregs) are thought to modulate immune responses during Brain death (BD), However findings on their role remain controversial. This study aimed to assess the frequency of circulating Tregs in the peripheral blood of non-traumatic BD cases, specifically focusing on CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low/-</sup>CD39<sup>+</sup> Tregs and the levels of inflammatory cytokine mRNA in BD individuals.</p><p><strong>Methods: </strong>The percentage of CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low/-</sup>CD39<sup>+</sup> Tregs was measured using flow cytometry in BD patients upon admission and in control subjects. Additionally, mRNA expression levels of interleukin (IL)-1β, IL-6, IL-8, IL-17, tumor necrosis factor (TNF)-α and Interferon (IFN)-γ were quantified in peripheral blood mononuclear cells (PBMCs) from 28 BD individuals and 28 controls using real-time polymerase chain reaction.</p><p><strong>Results: </strong>CD39<sup>+</sup> Tregs were significantly reduced in non-traumatic BD cases compared with control group (P < 0.0001). Moreover, the expression levels of IL-1β, IL-6, IL-8, IL-17a, IFN-ɣ, and TNF-α were significantly elevated in non-traumatic BD cases compared to the control group (P < 0.01, P < 0.05, P < 0.01, P < 0.0001, P < 0.0001, P < 0.001 respectively).</p><p><strong>Conclusion: </strong>This study provides novel evidence of reduced CD39<sup>+</sup> Tregs in the peripheral blood of non-traumatic BD patients, accompanied by increased inflammatory cytokine gene expression. Further investigations are needed to explore the underlying mechanisms and potential therapeutic implications.</p>","PeriodicalId":23304,"journal":{"name":"Transplant immunology","volume":" ","pages":"102219"},"PeriodicalIF":1.6000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplant immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.trim.2025.102219","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose: Regulatory T cells (Tregs) are thought to modulate immune responses during Brain death (BD), However findings on their role remain controversial. This study aimed to assess the frequency of circulating Tregs in the peripheral blood of non-traumatic BD cases, specifically focusing on CD4+CD25+CD127low/-CD39+ Tregs and the levels of inflammatory cytokine mRNA in BD individuals.
Methods: The percentage of CD4+CD25+CD127low/-CD39+ Tregs was measured using flow cytometry in BD patients upon admission and in control subjects. Additionally, mRNA expression levels of interleukin (IL)-1β, IL-6, IL-8, IL-17, tumor necrosis factor (TNF)-α and Interferon (IFN)-γ were quantified in peripheral blood mononuclear cells (PBMCs) from 28 BD individuals and 28 controls using real-time polymerase chain reaction.
Results: CD39+ Tregs were significantly reduced in non-traumatic BD cases compared with control group (P < 0.0001). Moreover, the expression levels of IL-1β, IL-6, IL-8, IL-17a, IFN-ɣ, and TNF-α were significantly elevated in non-traumatic BD cases compared to the control group (P < 0.01, P < 0.05, P < 0.01, P < 0.0001, P < 0.0001, P < 0.001 respectively).
Conclusion: This study provides novel evidence of reduced CD39+ Tregs in the peripheral blood of non-traumatic BD patients, accompanied by increased inflammatory cytokine gene expression. Further investigations are needed to explore the underlying mechanisms and potential therapeutic implications.
期刊介绍:
Transplant Immunology will publish up-to-date information on all aspects of the broad field it encompasses. The journal will be directed at (basic) scientists, tissue typers, transplant physicians and surgeons, and research and data on all immunological aspects of organ-, tissue- and (haematopoietic) stem cell transplantation are of potential interest to the readers of Transplant Immunology. Original papers, Review articles and Hypotheses will be considered for publication and submitted manuscripts will be rapidly peer-reviewed and published. They will be judged on the basis of scientific merit, originality, timeliness and quality.